Gray Kueberuwa

48 Grafton St
Manchester, ENG M139XX, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Engineering strategies to optimise adoptive cell therapy in ovarian cancer.

Engineering strategies to optimise adoptive cell therapy in ovarian cancer.

Journal: Cancer treatment reviews
Published: August 08, 2023

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes.

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes.

Journal: Frontiers in immunology
Published: July 10, 2023

Clinical feasibility and treatment outcomes with nonselected autologous tumor-infiltrating lymphocyte therapy in patients with advanced cutaneous melanoma.

Clinical feasibility and treatment outcomes with nonselected autologous tumor-infiltrating lymphocyte therapy in patients with advanced cutaneous melanoma.

Journal: American journal of cancer research
Published: June 15, 2022

Transgenic T-cell receptor immunotherapy for cancer: building on clinical success.

Transgenic T-cell receptor immunotherapy for cancer: building on clinical success.

Journal: Therapeutic advances in vaccines and immunotherapy
Published: November 07, 2019

Impact of Polymer-TLR-7/8 Agonist (Adjuvant) Morphology on the Potency and Mechanism of CD8 T Cell Induction.

Impact of Polymer-TLR-7/8 Agonist (Adjuvant) Morphology on the Potency and Mechanism of CD8 T Cell Induction.

Journal: Biomacromolecules
Published: January 05, 2019

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells.

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells.

Journal: Journal of visualized experiments : JoVE
Published: November 06, 2018

CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity.

CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity.

Journal: Molecular therapy oncolytics
Published: December 13, 2017

Optogenetic control of iPS cell-derived neurons in 2D and 3D culture systems using channelrhodopsin-2 expression driven by the synapsin-1 and calcium-calmodulin kinase II promoters.

Optogenetic control of iPS cell-derived neurons in 2D and 3D culture systems using channelrhodopsin-2 expression driven by the synapsin-1 and calcium-calmodulin kinase II promoters.

Journal: Journal of tissue engineering and regenerative medicine
Published: November 01, 2017

CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo.

CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo.

Journal: Journal for immunotherapy of cancer
Published: November 04, 2016

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators.

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators.

Journal: Molecular therapy oncolytics
Published: July 19, 2016

CAR T-cell therapy: toxicity and the relevance of preclinical models.

CAR T-cell therapy: toxicity and the relevance of preclinical models.

Journal: Immunotherapy
Published: June 13, 2015

Tissue-specific attenuation of oncolytic sindbis virus without compromised genetic stability.

Tissue-specific attenuation of oncolytic sindbis virus without compromised genetic stability.

Journal: Human gene therapy methods
Published: February 27, 2014
Showing 1-12 of 12

Last Updated: 09/26/2026